MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms

Oncogene

Volumn 32, Issue 3, 2013, Pages 296-306

  Liu, Y N ^a   Yin, J J ^a   Abou Kheir, W ^a   Hynes, P G ^a   Casey, O M ^a   Fang, L ^a   Yi, M ^b   Stephens, R M ^b   Seng, V ^a   Sheppard Tillman, H ^a   Martin, P ^a,b   Kelly, K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

EMT; miR 1; miR 200; prostate cancer; SLUG

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 200; MICRORNA 200B; TRANSCRIPTION FACTOR SLUG; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL LINEAGE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MESENCHYME; MESENCHYME CELL; MOLECULAR INTERACTION; NEGATIVE FEEDBACK; NONHUMAN; PHYLOGENY; PLEIOTROPY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; REGULATORY MECHANISM; SARCOMATOID CARCINOMA; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICRORNAS; PROSTATIC NEOPLASMS; PTEN PHOSPHOHYDROLASE; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84872608167     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.58     Document Type: Article

References (34)

1. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
2. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009; 9: 265-273.
3. Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA. A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res 2007; 13: 7003-7011.
4. Jaggi M, Nazemi T, Abrahams NA, Baker JJ, Galich A, Smith LM et al. N-cadherin switching occurs in high Gleason grade prostate cancer. Prostate 2006; 66: 193-199.
5. Alonso-Magdalena P, Brossner C, Reiner A, Cheng G, Sugiyama N, Warner M et al. A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia. Proc Natl Acad Sci USA 2009; 106: 2859-2863.
6. Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res 2009; 19: 156-172.
7. Ao M, Williams K, Bhowmick NA, Hayward SW. Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. Cancer Res 2006; 66: 8007-8016.
8. Jones E, Pu H, Kyprianou N. Targeting TGF-beta in prostate cancer: therapeutic possibilities during tumor progression. Expert Opin Ther Targets 2009; 13: 227-234.
9. Adler HL, McCurdy MA, Kattan MW, Timme TL, Scardino PT, Thompson TC. Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma. J Urol 1999; 161: 182-187.
10. Wikstrom P, Stattin P, Franck-Lissbrant I, Damber JE, Bergh A. Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer. Prostate 1998; 37: 19-29.
11. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 2008; 9: 582-589.
12. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593-601.
13. Iliopoulos D, Lindahl-Allen M, Polytarchou C, Hirsch HA, Tsichlis PN, Struhl K. Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. Mol Cell 2010; 39: 761-772.
14. Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009; 138: 592-603.
15. Martin P, Liu Y, Pierce R, Abou-Kheir WG, Casey O, Seng V et al. Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition. Am J Pathol 2011; 179: 422-435.
16. Hansel DE, Epstein JI. Sarcomatoid carcinoma of the prostate: a study of 42 cases. Am J Surg Pathol 2006; 30: 1316-1321.
17. Liu YN, Abou-Kheir W, Yin JJ, Fang L, Hynes P, Casey O et al. Critical and reciprocal regulation of KLF4 and SLUG in TGFbeta-initiated prostate cancer EMT. Mol Cell Biol 2011; 32: 941-953.
18. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A et al. The EMTactivator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 2009; 11: 1487-1495.
19. Lambertini E, Lisignoli G, Torreggiani E, Manferdini C, Gabusi E, Franceschetti T et al. Slug gene expression supports human osteoblast maturation. Cell Mol Life Sci 2009; 66: 3641-3653.
20. Torreggiani E, Lisignoli G, Manferdini C, Lambertini E, Penolazzi L, Vecchiatini R et al. Role of Slug transcription factor in human mesenchymal stem cells. J Cell Mol Med 2011; (e-pub ahead of print 7 June 2011; doi:10.1111/j.1582-4934. 2011.01352.x.).
21. Molchadsky A, Shats I, Goldfinger N, Pevsner-Fischer M, Olson M, Rinon A et al. P53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner. PLoS One 2008; 3: e3707.
22. Chang CJ, Chao CH, Xia W, Yang JY, Xiong Y, Li CW et al. P53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 2011; 13: 317-323.
23. Wang SP, Wang WL, Chang YL, Wu CT, Chao YC, Kao SH et al. P53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat Cell Biol 2009; 11: 694-704.
24. Casas E, Kim J, Bendesky A, Ohno-Machado L, Wolfe CJ, Yang J. Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res 2011; 71: 245-254.
25. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F et al. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 2008; 68: 6162-6170.
26. Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S et al. Methylation mediated silencing of microRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 2008; 68: 5049-5058.
27. Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, Majumder S et al. Downregulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J Biol Chem 2008; 283: 33394-33405.
28. Suzuki H, Takatsuka S, Akashi H, Yamamoto E, Nojima M, Maruyama R et al. Genome-wide profiling of chromatin signatures reveals epigenetic regulation of microRNA genes in colorectal cancer. Cancer Res 2011; 71: 5646-5658.
29. Ganem NJ, Compton DA. The KinI kinesin Kif2a is required for bipolar spindle assembly through a functional relationship with MCAK. J Cell Biol 2004; 166: 473-478.
30. Day CP, Carter J, Bonomi C, Esposito D, Crise B, Ortiz-Conde B et al. Lentivirusmediated bifunctional cell labeling for in vivo melanoma study. Pigment Cell Melanoma Res 2009; 22: 283-295.
31. Abou-Kheir WG, Hynes PG, Martin PL, Pierce R, Kelly K. Characterizing the contribution of stem/progenitor cells to tumorigenesis in the Pten, TP53prostate cancer model. Stem Cells 2010; 28: 2129-2140.
32. Ward Y, Lake R, Yin JJ, Heger CD, Raffeld M, Goldsmith PK et al. LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHOdependent signaling and invasion in prostate cancer cells. Cancer Res 2011; 71: 7301-7311.
33. Yin J, Pollock C, Tracy K, Chock M, Martin P, Oberst M et al. Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone. Mol Cell Biol 2007; 27: 7538-7550.
34. Zhu M, Yi M, Kim CH, Deng C, Li Y, Medina D et al. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage. Genome Biol 2011; 12: R77.